======= USPL1 ======= == Gene Information == * **Official Symbol**: USPL1 * **Official Name**: ubiquitin specific peptidase like 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10208|10208]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5W0Q7|Q5W0Q7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=USPL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USPL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617470|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: SUMO-specific isopeptidase involved in protein desumoylation. Specifically binds SUMO proteins with a higher affinity for SUMO2 and SUMO3 which it cleaves more efficiently. Also able to process full-length SUMO proteins to their mature forms (PubMed:22878415). Plays a key role in RNA polymerase-II- mediated snRNA transcription in the Cajal bodies (PubMed:24413172). Is a component of complexes that can bind to U snRNA genes (PubMed:24413172). {ECO:0000269|PubMed:22878415, ECO:0000269|PubMed:24413172}. No Pfam Domain information is available for this gene. |SUMO-specific isopeptidase activity| |Cajal body organization| |protein desumoylation| |SUMO binding| |nuclear body organization| |Cajal body| |snRNA transcription| |ubiquitin binding| |ncRNA transcription| |nucleus organization| |protein modification by small protein removal| |peptidyl-lysine modification| |cell population proliferation| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |peptidyl-amino acid modification| |protein modification by small protein conjugation or removal| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |proteolysis| |organic cyclic compound biosynthetic process| |extracellular space| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp131|L-74142 5μM R03 exp131]]|1.7| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.75| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.543| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.451| |[[:human genes:n:nol12|NOL12]]|0.436| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.432| |[[:human genes:o:ogfr|OGFR]]|0.413| |[[:human genes:n:npipb5|NPIPB5]]|0.413| |[[:human genes:n:narfl|NARFL]]|0.412| |[[:human genes:t:tbc1d3|TBC1D3]]|0.406| |[[:human genes:r:rrn3|RRN3]]|0.405| |[[:human genes:t:tbc1d3f|TBC1D3F]]|0.404| Global Fraction of Cell Lines Where Essential: 408/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|20/28| |blood|13/28| |bone|9/26| |breast|13/33| |central nervous system|36/56| |cervix|4/4| |colorectal|7/17| |esophagus|7/13| |fibroblast|1/1| |gastric|10/16| |kidney|10/21| |liver|13/20| |lung|45/75| |lymphocyte|5/16| |ovary|16/26| |pancreas|13/24| |peripheral nervous system|9/16| |plasma cell|10/15| |prostate|0/1| |skin|13/24| |soft tissue|5/9| |thyroid|1/2| |upper aerodigestive|12/22| |urinary tract|16/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1964 * **Expression level (log2 read counts)**: 5.74 {{:chemogenomics:nalm6 dist.png?nolink |}}